Cargando…
Topical Skullcapflavone II attenuates atopic dermatitis in a mouse model by directly inhibiting associated cytokines in different cell types
Skullcapflavone II (SFII), a flavonoid derived from Scutellaria baicalensis, is an anticancer agent. We aimed to validate SFII for atopic dermatitis (AD) therapy by demonstrating the anti-inflammatory effects of SFII in an AD mouse model produced by the topical application of the vitamin D3 analog M...
Autores principales: | Lee, Youngae, Oh, Jang-Hee, Li, Na, Jang, Hyun-Jae, Ahn, Kyung-Seop, Oh, Sei-Ryang, Lee, Dong Hun, Chung, Jin Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808403/ https://www.ncbi.nlm.nih.gov/pubmed/36605189 http://dx.doi.org/10.3389/fimmu.2022.1064515 |
Ejemplares similares
-
Corrigendum: Topical Skullcapflavone II attenuates atopic dermatitis in a mouse model by directly inhibiting associated cytokines in different cell types
por: Lee, Youngae, et al.
Publicado: (2023) -
Skullcapflavone II Suppresses TNF-α/IFN-γ-Induced TARC, MDC, and CTSS Production in HaCaT Cells
por: Lee, Hanon, et al.
Publicado: (2021) -
Purpurin suppresses atopic dermatitis via TNF-α/IFN-γ-induced inflammation in
HaCaT cells
por: Oh, Jae-Hoon, et al.
Publicado: (2022) -
Topical Tacrolimus for the Treatment of Atopic Dermatitis with Truncal Lesion
por: Ko, Hyun Chang, et al.
Publicado: (2018) -
Quercetin Attenuates the Production of Pro-Inflammatory Cytokines in H292 Human Lung Epithelial Cells Infected with Pseudomonas aeruginosa by Modulating ExoS Production
por: Ahn, Hye In, et al.
Publicado: (2023)